EuBioNet (@EuBioNet) profile picture

The European Biotechnology Network facilitates cooperation across all biotechnology sectors and organisations for the economic delivery of science in Europe.

Brussels
Joined May 2011
Open calls for European Gram Negative Anti-Bacterial Engine, click for details of funding ow.ly/uHQvt #microbiology #antibiotics
2
1
IMI call for novel G Neg anti-infectives. Deadline sept 9 for 3 pg EoI with support webinars for applicants. nd4bb-enable.eu/open-calls
IMI project ENABLE showcased at BIO San Diego. Visit nd4bb-enable.eu for slides from GSK, @MedinaDiscovery , Asclepia and Redx Pharma
€85m European project for novel antibiotics: ENABLE. A 6 yr project aims to bring gram negative candidates to trial. european-biotechnology.net/a…
2
1
Workshop: H2020 as strategic business tools for life science SMEs. March 27, Brussels. Free to EBN Corporate members. european-biotechnology.net/e…
A #yeast strain created by #synbio promise to solve the tank-or-table dilemma making #biofuels from #brown #algae. european-biotechnology-news.…
New network event coming up! Join us on the #webinar on #bigdata in collaborative research See bit.ly/1et8UvO for more.
Dutch-US investment firm #Gilde #Healthcare has #closed a €145m transatlantic growth capital #fund. european-biotechnology-news.…
1
1
Join us for World #Bio #Markets 2014! #EuroBioNet members get 20% #discount! Details on: bit.ly/1dxXLxp
A new #centre dedicated to perform first-in-man #trials in #neurodegenerative #disorders has been #opened in London. european-biotechnology-news.…
The EMA has postponed the implementation of new rules for disclosing clinical raw trial data. eurobiotechnews.eu/news/news…
Belgian #Galapagos British subsidiary #BioFocus will screen and validate new #scleroderma targets for #Biogen Idec. eurobiotechnews.eu/news/news…
1
1
#Shire plc gets a foothold in the #orphan #drug business by swallowing US company #ViroPharma for US$4.2bn. eurobiotechnews.eu/news/news…
#Roche's glyco-optimised CD20 blocker #Gazyva (obinutuzumab) #extends progression-free #survival compared to Rituxan. eurobiotechnews.eu/news/news…
The UK's BBSRC has kicked off an £10m #investment #fund dedicated to #biotechs that are active in #synthetic #biology.eurobiotechnews.eu/news/news…
Webinars on #CNS research, #Bigdata and many more to come! See: bit.ly/1cqfGFC
1